This review provides a historical summary of pivotal heart failure and post-infarction trials presented at the AHA 2000 scientific sessions.
Offers no current clinical guidance; leaves open how 2000 trial findings integrate with post-2000 advances.
This article continues a series of reports summarising recent research developments pertinent to the topic of heart failure. This is a summary of presentations made at scientific sessions of the American Heart Association in November 2000. Clinical studies of particular interest to people caring for patients with heart failure include Val-HeFT, AMIOVIRT and V-MAC. New data from beta-blockers trials are reviewed, highlights from some important developments in post-infarction care, including MIRACL and FLORIDA, discussed and results of some early studies of gene therapy reported.
No takes yet. Share an insight, caveat, or question.
Thackray et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: